Casi Pharmaceuticals Inc Quick Ratio (CASIF) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Casi Pharmaceuticals inc   (CASIF)

Casi Pharmaceuticals Inc 's Quick Ratio

CASIF's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Casi Pharmaceuticals Inc 's Cash & cash equivalent grew by 30.47 % in the Q4 2025 sequentially, faster than Current Liabilities, this led to improvement in Casi Pharmaceuticals Inc 's Quick Ratio to 0.14, Quick Ratio remained below Casi Pharmaceuticals inc average.

Within Major Pharmaceutical Preparations industry 431 other companies have achieved higher Quick Ratio than Casi Pharmaceuticals Inc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 3880.

Explain Quick Ratio?
How much Cash & cash equivalents CASIF´s has?
What are CASIF´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CASIF Quick Ratio (Dec 31 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change -5.35 % 36.26 % 36.26 % 36.26 % 89.64 %
Y / Y Cash & cash equivalent Change -51.61 % -58.18 % -58.18 % -58.18 % -12.72 %
Quick Ratio MRQ 0.14 0.11 0.11 0.11 0.28
CASIF's Total Ranking # 3880 # # # #
Seq. Current Liabilities Change 3.53 % 0 % 0 % -8.58 % 49.04 %
Seq. Cash & cash equivalent Change 30.47 % 0 % 0 % -62.91 % 12.74 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 432
Healthcare Sector # 854
Overall Market # 3880


Quick Ratio Statistics
High Average Low
2.93 0.91 0.11
(Dec 31 2022)   (Dec 31 2025)




Financial Statements
Casi Pharmaceuticals Inc 's Current Liabilities $ 51 Millions Visit CASIF's Balance sheet
Casi Pharmaceuticals Inc 's Cash & cash equivalent $ 7 Millions Visit CASIF's Balance sheet
Source of CASIF's Sales Visit CASIF's Sales by Geography


Cumulative Casi Pharmaceuticals Inc 's Quick Ratio

CASIF's Quick Ratio for the trailling 12 Months

CASIF Quick Ratio

 (Dec 31 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 22.45 % 47.34 % 60.74 % 79.5 % 107.65 %
Y / Y Cash & cash equivalent TTM Growth -56.39 % -44.5 % -45.64 % -46.38 % -46.9 %
Quick Ratio TTM 0.12 0.16 0.21 0.27 0.34
Total Ranking TTM # 4829 # # # #
Seq. Current Liabilities TTM Growth -1.43 % 6.95 % 7.47 % 8.08 % 18.61 %
Seq. Cash & cash equivalent TTM Growth -24.43 % -19.63 % -16.41 % -14.1 % -3.83 %

Quick ratio ranking by company, industry and sector >> Back to CASIF Financial Strength Comparisons >> Go to Compare CASIF Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CASIF's Current Liabilities to $51.43 millions, cumulative Quick Ratio to 0.12 below the CASIF average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 494 other companies have achieved higher Quick Ratio than Casi Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 4829.

Explain Quick Ratio?
How much Cash & cash equivalents CASIF´s has?
What are CASIF´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 495
Healthcare Sector # 1015
Within the Market # 4829


trailing twelve months Quick Ratio Statistics
High Average Low
1.74 0.61 0.12
(Dec 31 2023)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Tiziana Life Sciences Ltd  0.36 $ 4.010  Millions$ 11.209  Millions
Ac Immune Sa  0.36 $ 33.764  Millions$ 94.693  Millions
Amneal Pharmaceuticals Inc   0.35 $ 310.871  Millions$ 881.633  Millions
Lftd Partners Inc   0.35 $ 1.817  Millions$ 5.162  Millions
Genmab A  0.34 $ 269.485  Millions$ 785.827  Millions
Aditxt Inc   0.34 $ 3.358  Millions$ 9.902  Millions
Medicure Inc   0.33 $ 2.938  Millions$ 8.896  Millions
Protagenic Therapeutics Inc new  0.32 $ 2.213  Millions$ 6.824  Millions
Sanofi  0.29 $ 9,105.134  Millions$ 31,746.400  Millions
Nrx Pharmaceuticals Inc   0.27 $ 7.797  Millions$ 28.578  Millions
Telix Pharmaceuticals Ltd  0.27 $ 147.909  Millions$ 542.825  Millions
Biolinerx Ltd   0.27 $ 3.250  Millions$ 12.123  Millions
Summit Therapeutics Inc   0.27 $ 16.538  Millions$ 61.966  Millions
Cumberland Pharmaceuticals Inc   0.26 $ 11.445  Millions$ 44.519  Millions
Teva Pharmaceutical Industries Limited  0.25 $ 3,556.000  Millions$ 14,068.000  Millions
Organon and Co   0.24 $ 574.000  Millions$ 2,390.000  Millions
Galapagos Nv  0.23 $ 40.000  Millions$ 171.207  Millions
Hcw Biologics Inc   0.23 $ 1.953  Millions$ 8.625  Millions
International Stem Cell Corporation  0.22 $ 0.993  Millions$ 4.579  Millions
Intercure Ltd   0.22 $ 46.466  Millions$ 214.365  Millions
Redhill Biopharma Ltd   0.21 $ 3.971  Millions$ 19.221  Millions
Polomar Health Services, Inc.  0.21 $ 0.141  Millions$ 0.687  Millions
Quantum Cyber N v   0.20 $ 0.832  Millions$ 4.240  Millions
Adlai Nortye Ltd  0.19 $ 8.056  Millions$ 41.628  Millions
Viatris Inc   0.19 $ 1,388.100  Millions$ 7,420.600  Millions
Igc Pharma Inc   0.18 $ 0.405  Millions$ 2.257  Millions
Citius Oncology Inc  0.16 $ 7.295  Millions$ 44.710  Millions
Bioxytran Inc   0.16 $ 0.510  Millions$ 3.147  Millions
Neurosense Therapeutics Ltd  0.16 $ 0.213  Millions$ 1.358  Millions
Pmgc Holdings Inc   0.15 $ 0.572  Millions$ 3.942  Millions

Date modified: 2026-09-08T15:11:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.